Eric Feinstein
Chief Executive Officer at Clarapath, Inc.
Profile
Eric S.
Feinstein is currently the Chief Executive Officer & Executive Director at Clarapath, Inc. and an Investment Review Committee Member at Accelerate Long Island (Venture Capital).
He previously worked as a Director at Resources Connection, Inc., PurpleSun, Inc., and Northwell Holdings.
He was also an Associate at Ampersand Management LLC and an Analyst at Ares Secondaries Group.
Additionally, he holds the title of Principal at Salomon Smith Barney.
Mr. Feinstein received his undergraduate degree from Trinity College (Connecticut) and his MBA from SC Johnson College of Business.
Eric Feinstein active positions
Companies | Position | Start |
---|---|---|
Clarapath, Inc.
Clarapath, Inc. Medical SpecialtiesHealth Technology Clarapath, Inc. develops anatomic pathology device. The firm offers routine histology, pathology consultation, whole slide imaging, quantitative image analysis and long term data management services. The company is headquartered in New York, NY. | Chief Executive Officer | 2018-01-31 |
Accelerate Long Island (Venture Capital)
Accelerate Long Island (Venture Capital) Investment ManagersFinance Accelerate Long Island/venture capital/ (Accelerate Long Island (Venture Capital)) is a venture capital firm, a subsidiary of Accelerate Long Island, Inc founded in 2016. The firm is headquartered in Melville, New York. | Private Equity Investor | - |
Former positions of Eric Feinstein
Companies | Position | End |
---|---|---|
Northwell Holdings
Northwell Holdings Investment ManagersFinance Northwell Holdings is a venture capital subsidiary of Northwell Health, Inc. founded in 2013. The firm is headquartered in New York. | Director/Board Member | 2021-10-30 |
PurpleSun, Inc.
PurpleSun, Inc. Packaged SoftwareTechnology Services PurpleSun, Inc. is a technology company that designs and manufactures hospital-grade ultraviolet light delivery systems for the purpose of disinfecting critical equipment and rooms with the highest efficacy and fastest speed. The private company is based in Long Island City, NY. PurpleSun is partnered with some of the largest healthcare systems and aims to become the world's leading brand in sustainable infection prevention solutions for patients, staff, and hospitals. The company's solutions allow for hospital-wide application, with one of the only products not requiring evacuation of the room during use. The company was founded in 2012 by Audrey McNicholas, Luis F. Romo, Wladyslaw Kowalski. David Lawrence Eigen has been the CEO of the company since 2021. | Director/Board Member | 2020-12-30 |
RESOURCES CONNECTION, INC. | Private Equity Investor | 2015-10-30 |
Ampersand Management LLC
Ampersand Management LLC Investment ManagersFinance Ampersand Management LLC (Ampersand Management) is a private equity firm founded in 1988 by Richard A. Charpie. The firm is headquartered in Wellesley, Massachusetts. | Private Equity Analyst | 2011-02-27 |
Ares Secondaries Group
Ares Secondaries Group Investment ManagersFinance Ares Secondaries Group (Ares Secondaries) is a private equity subsidiary of Ares Holdings LP founded in 1989 by Brent R.Nicklas. The firm is headquartered in Simsbury, Connecticut. | Private Equity Analyst | 2007-10-30 |
Training of Eric Feinstein
Trinity College (Connecticut) | Undergraduate Degree |
SC Johnson College of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
RESOURCES CONNECTION, INC. | Commercial Services |
Private companies | 7 |
---|---|
PurpleSun, Inc.
PurpleSun, Inc. Packaged SoftwareTechnology Services PurpleSun, Inc. is a technology company that designs and manufactures hospital-grade ultraviolet light delivery systems for the purpose of disinfecting critical equipment and rooms with the highest efficacy and fastest speed. The private company is based in Long Island City, NY. PurpleSun is partnered with some of the largest healthcare systems and aims to become the world's leading brand in sustainable infection prevention solutions for patients, staff, and hospitals. The company's solutions allow for hospital-wide application, with one of the only products not requiring evacuation of the room during use. The company was founded in 2012 by Audrey McNicholas, Luis F. Romo, Wladyslaw Kowalski. David Lawrence Eigen has been the CEO of the company since 2021. | Technology Services |
Ampersand Management LLC
Ampersand Management LLC Investment ManagersFinance Ampersand Management LLC (Ampersand Management) is a private equity firm founded in 1988 by Richard A. Charpie. The firm is headquartered in Wellesley, Massachusetts. | Finance |
Ares Secondaries Group
Ares Secondaries Group Investment ManagersFinance Ares Secondaries Group (Ares Secondaries) is a private equity subsidiary of Ares Holdings LP founded in 1989 by Brent R.Nicklas. The firm is headquartered in Simsbury, Connecticut. | Finance |
Salomon Smith Barney | Finance |
Northwell Holdings
Northwell Holdings Investment ManagersFinance Northwell Holdings is a venture capital subsidiary of Northwell Health, Inc. founded in 2013. The firm is headquartered in New York. | Finance |
Accelerate Long Island (Venture Capital)
Accelerate Long Island (Venture Capital) Investment ManagersFinance Accelerate Long Island/venture capital/ (Accelerate Long Island (Venture Capital)) is a venture capital firm, a subsidiary of Accelerate Long Island, Inc founded in 2016. The firm is headquartered in Melville, New York. | Finance |
Clarapath, Inc.
Clarapath, Inc. Medical SpecialtiesHealth Technology Clarapath, Inc. develops anatomic pathology device. The firm offers routine histology, pathology consultation, whole slide imaging, quantitative image analysis and long term data management services. The company is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Eric Feinstein